Assessment of myocardial fibrosis in patients with systemic sclerosis using [(68)Ga]Ga-FAPI-04-PET-CT

PURPOSE: Myocardial fibrosis (MF) is a factor of poor prognosis in systemic sclerosis (SSc). Direct in-vivo visualization of fibroblast activation as early readout of MF has not been feasible to date. Here, we characterize (68)Gallium-labeled-Fibroblast-Activation-Inhibitor-04 ([(68)Ga]Ga-FAPI-04)-P...

Descripción completa

Detalles Bibliográficos
Autores principales: Treutlein, Christoph, Distler, Jörg H. W., Tascilar, Koray, Fakhouri, Sara Chenguiti, Györfi, Andrea-Hermina, Atzinger, Armin, Matei, Alexandru-Emil, Dees, Clara, Büttner-Herold, Maike, Kuwert, Torsten, Prante, Olaf, Bäuerle, Tobias, Uder, Michael, Schett, Georg, Schmidkonz, Christian, Bergmann, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119041/
https://www.ncbi.nlm.nih.gov/pubmed/36522438
http://dx.doi.org/10.1007/s00259-022-06081-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119041/
https://www.ncbi.nlm.nih.gov/pubmed/36522438
http://dx.doi.org/10.1007/s00259-022-06081-4

Ejemplares similares